2026-06-13

ETH open interest -69.1% - OI collapse

BTC open interest +90.9% - OI surge

SOL open interest -74.2% - OI collapse

ETH open interest -63.6% - OI collapse

BTC open interest +218.7% - OI surge

SOL open interest +277.2% - OI surge

USDC/USDT has $155.8M volume but only $884K liquidity - thin market, slippage risk

SOL open interest -24.2% - OI collapse

ETH open interest -63.5% - OI collapse

BTC open interest -42.8% - OI collapse

BTC open interest -42.8% - OI collapse

SOL open interest -64.0% - OI collapse

ETH open interest -68.8% - OI collapse

SOL DEX volume/liquidity ratio elevated (0.67x) - strong on-chain trading activity

OSINT: CFTC Chair Selig Pushes Onshore Innovation, New Derivatives Under Gold Standard

SOL DEX volume/liquidity ratio elevated (0.90x) - strong on-chain trading activity

SOL DEX volume/liquidity ratio elevated (0.90x) - strong on-chain trading activity

OSINT: USA beats Paraguay 4-1 in international soccer match

OSINT: Drivechains Proposed to Add Privacy, Smart Contracts, Larger Blocks to Bitcoin

Silver bull 6.2% vs prior close ($63.88 → $67.86)

Gold +3.05% - significant rally

OSINT: Iran to Charge Vessels for Services in Strait of Hormuz, Manage Safe Passage

Gold +3.05% - significant rally

OSINT: Oil Prices Stay Sub-$100 on China slowdown and demand destruction

CFTC SILVER speculator at extreme short - contrarian bull signal

Gold +3.05% - significant rally

OSINT: Iranian ballistic missile intercepted west of Jerusalem

Oil -3.90% - significant selloff

Gold +3.66% - significant rally

Oil -3.23% - significant selloff

OSINT: US aid to Ukraine halted after Putin's warning, Trump reverses support

Oil -3.23% - significant selloff

OSINT: NATO Plans Large-Scale Exercises Near Russia and Belarus

OSINT: Ukrainian Drone Strikes Isolate Crimea, Threaten Energy Links

OSINT: Iran Deploys Attack Drones Targeting Commercial Vessels in Strait of Hormuz

Oil -3.23% - significant selloff

Gold bull 3.0% vs prior close ($4,090.30 → $4,215.00)

Heating Oil bear 3.1% vs prior close ($3.51 → $3.40)

WTI Crude Oil bear 3.2% vs prior close ($87.71 → $84.88)

Phase 3 trial terminated early - JOHNSON A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Dise

Phase 3 trial terminated early - JOHNSON An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the

Phase 3 trial terminated early - JOHNSON To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Canc

Phase 3 trial terminated early - ELI Abciximab in Wake-up Stroke

Phase 3 trial terminated early - ELI A Study for Patients With Multiple Sclerosis

Phase 3 trial terminated early - ELI A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to C

Phase 3 trial terminated early - ELI Atomoxetine for Children With Acquired Attentional Disorders Following Completio

Phase 3 trial terminated early - BRISTOL A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants

Phase 3 trial terminated early - BRISTOL Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for T

Phase 3 trial terminated early - BRISTOL Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With

Phase 3 trial terminated early - BIOGEN Tecfidera Slow-Titration Study

Phase 3 trial terminated early - BIOGEN A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early

Phase 3 trial terminated early - AMGEN Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthrit

Phase 3 trial terminated early - INCYTE A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy i

Phase 3 trial terminated early - REGENERON Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermati

Phase 3 trial terminated early - REGENERON REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimum

Phase 3 trial terminated early - REGENERON Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gem

Phase 3 trial terminated early - Medtronic AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibri

Phase 3 trial terminated early - Medtronic Tibial Delayed Healing Pivotal Clinical Trial

Phase 3 trial terminated early - Medtronic OneShot Renal Denervation Registry

Phase 3 trial terminated early - AbbVie MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Tr

Phase 3 trial terminated early - AbbVie Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therap

Phase 3 trial terminated early - ABBOTT Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients W

Phase 3 trial terminated early - ABBOTT Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery D

Phase 3 trial terminated early - ABBOTT Creon in HIV Patients With Steatorrhea

Phase 3 trial terminated early - ABBOTT Niacin Plus Statin to Prevent Vascular Events

Phase 3 trial terminated early - PFIZER Study Evaluating Bifeprunox in Patients With Schizophrenia.

Phase 3 trial terminated early - PFIZER Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients

Phase 3 trial terminated early - PFIZER Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

Phase 3 trial terminated early - PFIZER Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study

Phase 3 trial terminated early - Merck Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Hea

Phase 3 trial terminated early - Merck Raptiva in Palm and Sole Psoriasis

Phase 3 trial terminated early - Merck A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sita

Phase 3 trial terminated early - Merck Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovari

Phase 3 trial terminated early - Merck Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Thera

Phase 3 trial terminated early - Merck Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morb

Phase 3 trial terminated early - Merck Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients

Phase 3 trial terminated early - Merck Cubicin(R) for Complicated Post-surgical Wound Infections

Phase 3 trial terminated early - Merck Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Phase 3 trial terminated early - GILEAD Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability

Phase 3 trial terminated early - GILEAD Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inh

Phase 3 trial terminated early - GILEAD Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab

Phase 3 trial terminated early - GILEAD Dose Optimization Study of Idelalisib in Follicular Lymphoma

PDD Holdings Inc. search volume spiked +100 pts - unusual interest

NEWMONT Corp /DE/ search volume spiked +31 pts - unusual interest

5 congress members traded CHRW - net BEAR (0B/0S)

6 congress members traded TSCO - net BEAR (0B/0S)

ASTRAZENECA PLC search volume spiked +87 pts - unusual interest

Seagate Technology Holdings plc search volume spiked +100 pts - unusual interest

ABBOTT LABORATORIES search volume spiked +54 pts - unusual interest

PDD Holdings Inc. search volume spiked +100 pts - unusual interest

NEWMONT Corp /DE/ search volume spiked +31 pts - unusual interest

5 congress members traded CHRW - net BEAR (0B/0S)

6 congress members traded TSCO - net BEAR (0B/0S)

ASTRAZENECA PLC search volume spiked +87 pts - unusual interest

Seagate Technology Holdings plc search volume spiked +100 pts - unusual interest

ABBOTT LABORATORIES search volume spiked +54 pts - unusual interest

CONOCOPHILLIPS search volume spiked +35 pts - unusual interest

PDD Holdings Inc. search volume spiked +100 pts - unusual interest

NEWMONT Corp /DE/ search volume spiked +31 pts - unusual interest

Q2-2026: Missed consensus by 35.4% - EPS $-0.29 vs $-0.2142 estimate

Beat consensus by 167.9% - EPS $0.09 vs $-0.1326 estimate

Missed consensus by 28.9% - EPS $-0.18 vs $-0.1396 estimate

Q1-2026: Missed consensus by 16.7% - EPS $-0.247 vs $-0.2116 estimate

Phase 3 trial completing - REGENERON awaiting FDA decision

Bond issued at elevated rate 4.9% - credit-stress signal

5 congress members traded CHRW - net BEAR (0B/0S)

6 congress members traded TSCO - net BEAR (0B/0S)

BITCOIN - speculators net long (+2.5σ vs 52w mean) - contrarian bear signal

NATURAL GAS - speculators net long (+2.3σ vs 52w mean) - contrarian bear signal

ASTRAZENECA PLC search volume spiked +87 pts - unusual interest

CONOCOPHILLIPS search volume spiked +35 pts - unusual interest

PDD Holdings Inc. search volume spiked +100 pts - unusual interest

NEWMONT Corp /DE/ search volume spiked +31 pts - unusual interest

OSINT: Drivechains Proposed to Add Privacy, Smart Contracts, Larger Blocks to Bitcoin

5 congress members traded CHRW - net BEAR (0B/0S)

6 congress members traded TSCO - net BEAR (0B/0S)

ASTRAZENECA PLC search volume spiked +87 pts - unusual interest

CONOCOPHILLIPS search volume spiked +35 pts - unusual interest

Q1-2027: EPS $0.08 vs $-0.0098 estimate, +0.09 on a near-zero consensus

OSINT: US aid to Ukraine halted after Putin's warning, Trump reverses support

OSINT: NATO Plans Large-Scale Exercises Near Russia and Belarus

OSINT: Iran Deploys Attack Drones Targeting Commercial Vessels in Strait of Hormuz

OSINT: USA beats Paraguay 4-1 in international soccer match

OSINT: US aid to Ukraine halted after Putin's warning, Trump reverses support

OSINT: NATO Plans Large-Scale Exercises Near Russia and Belarus

OSINT: Stabbing attempt on 17‑year‑old girl in Burnley sparks local safety concerns

OSINT: Ukrainian Drone Strikes Isolate Crimea, Threaten Energy Links

OSINT: Ukrainian Drone Strikes Isolate Crimea, Threaten Energy Links

OSINT: Iran Deploys Attack Drones Targeting Commercial Vessels in Strait of Hormuz

OSINT: Iran Deploys Attack Drones Targeting Commercial Vessels in Strait of Hormuz

Financial conditions loosening - NFCI at -0.51, liquidity supportive